Skip to search formSkip to main contentSkip to account menu

LY2109761

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

PyrazolesPyrroles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Knockdown of KDM2A inhibits proliferation associated with TGF-β expression in HEK293T cell
Lysine-specific demethylase 2A (KDM2A, also known as JHDM1A or FBXL11) plays an important role in regulating cell proliferation… 
2019
2019
Blocking transforming growth factor-beta reduces the migration and invasion of the residual tumour after TAE.
This study aimed to investigate the treatment effects of combining TAE therapy with LY2109761, a transforming growth factor-beta… 
2018
2018
Di-N-octylphthalate acts as a proliferative agent in murine cell hepatocytes by regulating the levels of TGF-β and pro-apoptotic proteins.
2017
2017
Estrogen receptor β inhibits prostate cancer cell proliferation through downregulating TGF-β1/IGF-1 signaling.
Recently, estrogen receptor β (ERβ) appears to be anti-proliferative and pro-apoptotic in normal prostate gland, but its role in… 
2015
2015
LY2109761 inhibits metastasis and enhances chemosensitivity in osteosarcoma MG-63 cells.
OBJECTIVE : Studies have shown that transforming growth factor-beta (TGF- β) is associated with metastasis and chemoresis - tance… 
2015
2015
The In�ammator�Microenvironment in �epatocellular Carcinoma : A Pivotal Role for Tumor-AssociatedMacrophages
Hepatocellular carcinoma (HCC) is one of the most common and aggressive human cancers worldwide. HCC is an example of in�ammation… 
2014
2014
Mesenchymal stem cells are sensitive to treatment with kinase inhibitors and ionizing radiation
IntroductionMesenchymal stem cells (MSCs) can regenerate damaged tissues and may therefore be of importance for normal tissue… 
2014
2014
Correction: Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II
2010
2010
Application of T cell-based transcriptomics to identify three candidate biomarkers for monitoring anti-TGFβR therapy
Objectives The development of targeted drugs would greatly benefit from the simultaneous identification of biomarkers to… 
2008
2008
TGF-β receptor kinase inhibitor LY2109761 reverses the anti-apoptotic effects of TGF-β1 in myelo-monocytic leukaemic cells co-cultured with stromal cells
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)